BTZ-Derived Benzisothiazolinones with In Vitro Activity against <i>Mycobacterium tuberculosis</i>-Reference-Cited by-同舟云学术

BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis

Published:2022-07-25 Issue:8 Volume:13 Page:1302-1310
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Richter Adrian¹^ORCID,Seidel Rüdiger W.¹^ORCID,Goddard Richard²^ORCID,Eckhardt Tamira¹,Lehmann Christoph¹,Dörner Julia¹,Siersleben Fabienne¹,Sondermann Theresia¹,Mann Lea¹,Patzer Michael²,Jäger Christian³^ORCID,Reiling Norbert⁴⁵^ORCID,Imming Peter¹^ORCID

Affiliation:

1. Martin-Luther-Universität Halle-Wittenberg, Wolfgang-Langenbeck-Strasse 4, 06120 Halle (Saale), Germany

2. Max-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, 45470 Mülheim an der Ruhr, Germany

3. Fraunhofer-Institut für Zelltherapie und Immunologie, Außenstelle Molekulare Wirkstoffbiochemie und Therapieentwicklung, Weinbergweg 22, 06120 Halle (Saale), Germany

4. Microbial Interface Biology, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany

5. German Center for Infection Research (DZIF), Site Hamburg-Lübeck-Borstel-Riems, 23845 Borstel, Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00215

Reference42 articles.

1. Anti-tuberculosis treatment strategies and drug development: challenges and priorities

2. Global Tuberculosis Report; World Health Organization: Geneva, Switzerland, 2021.

3. Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

4. Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis

5. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment;European Journal of Medicinal Chemistry;2024-11

2. Crystal structure and antimycobacterial evaluation of 2-(cyclohexylmethyl)-7-nitro-5-(trifluoromethyl)benzo[d]isothiazol-3(2H)-one;Acta Crystallographica Section E Crystallographic Communications;2023-11-30

3. Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents;Archiv der Pharmazie;2023-09-04

4. Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review;Journal of Biomolecular Structure and Dynamics;2023-07-03

5. Comprehensive coverage on anti-mycobacterial endeavour reported during 2022;European Journal of Medicinal Chemistry;2023-07